Complementary univariate tests of combinations of + 7/ − 10 and EGFR amplification in the TCGA validation set and the Jonsson et al. validation set showed inconsistent prognostic utility of these markers among histological grade 4 IDH-wildtype glioblastoma (Additional file 2: Fig. 12). Here, IDH1 is linked to glioblastoma.